The largest database of trusted experimental protocols

6 protocols using apamin

1

Krebs solution composition and reagents

Check if the same lab product or an alternative is used in the 5 most similar protocols
Composition of Krebs solution was (mmol/L) Na+ 137.5; K+ 5.9; Ca2+ 2.5; Mg2+ 1.2; HCO3– 15.5; H2PO4 1.2; Cl 134; and glucose 11.5. The solution was bubbled with 95% O2 and 5% CO2, and the pH of solution was maintained at 7.3–7.5. Reagents used in this study were RS100329, an α1A AR antagonist, and a P2Y1 purinoceptor antagonist from Tocris Bioscience (Ellisville, MO), TTX from Wako (Osaka, Japan), apamin from Peptide Institute (Osaka, Japan), and atropine, noradrenaline (NE), PE, L-NNA, ACh, ADP, propranolol, prazosin, BMY7378, an α1D ARs antagonist, from MilliporeSigma (Burlington, MA).
+ Open protocol
+ Expand
2

Pharmacological Modulation of Ion Channels

Check if the same lab product or an alternative is used in the 5 most similar protocols
Diltiazem and nifedipine were obtained from Sigma-Aldrich, paxilline was obtained from Enzo Life Sciences, tetrodotoxin (TTX) was obtained from Tocris Bioscience, and apamin was obtained from Peptides International.
+ Open protocol
+ Expand
3

Pharmacological Compounds for Cellular Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
GSK101 [N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl) sulfonyl] amino}-3-hydroxy-propanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide] was obtained from Sigma-Aldrich. CPA, U73122, PMA, OAG, and Gö-6976 were obtained from EMD Chemicals. HC-067047 (2-methyl-1-[3-(4-morpholinyl)propyl]-5-phenyl-N-[3-(trifluoromethyl)phenyl]-1H–pyrrole-3-carboxamide) was a gift from Hydra Biosciences. Charybdotoxin and apamin were purchased from Peptide Institute and Enzo Life Sciences, respectively. All other chemicals were obtained from Sigma-Aldrich.
+ Open protocol
+ Expand
4

Krebs' Solution Preparation for Tissue Experiments

Check if the same lab product or an alternative is used in the 5 most similar protocols
During experiments, tissues were maintained in Krebs’ solution consisting of (mM): NaCl 118.4, KCl 4.7, CaCl2 2.5, MgSO4 1.2, KH2PO4 1.2, NaHCO3 25 and glucose 11.7. ATP, tetraethylammonium chloride (TEA), tetrodotoxin, atropine sulfate monohydrate and carbachol were obtained from FUJIFILM-Wako (Osaka, Japan). D-tubocurarine, suramin, methoctramine hydrate, 4-diphenylacetoxy-N-methyl-piperidine methiodide (4-DAMP), pyridoxal phosphate-6-azophenyl-2,4-disulfonic acid (PPADS), cibacron blue F3GA (CBF3GA; synonym reactive blue 2) and 4-aminopyridine (4-AP) were obtained from Sigma-Aldrich (St Louis, MO, USA). Glibenclamide and nicorandil were obtained from Tokyo Chemical Industry (Tokyo, Japan). GSK1016790A was obtained from Cayman Chemical (Ann Arbor, MI, USA). Apamin was obtained from Peptide Institute (Osaka, Japan). tetrodotoxin was dissolved in citrate solution. Glibenclamide, nicorandil and GSK1016790A were dissolved in DMSO. Other drugs were dissolved in distilled water. The highest concentration of vehicles (0.1%) for the drugs alone had no effect on the basal tone and contractile responses at the concentrations used. The concentrations of drugs given were final concentrations in the bath solution.
+ Open protocol
+ Expand
5

Krebs Solution Composition and Reagents

Check if the same lab product or an alternative is used in the 5 most similar protocols
Composition of Krebs solution was (mM): Na+ 137.5; K+ 5.9; Ca2+ 2.5; Mg2+ 1.2; HCO3- 15.5; H2PO4- 1.2; Cl- 134; glucose 11.5. The solution was bubbled with 95% O2 and 5% CO2 and the pH of solution was maintained at 7.3 to 7.5. Reagents used in this study were: PACAP-38 (PACAP in this study), PACAP 6-38 (selective PAC1R antagonist), Maxadilan (selective PAC1R agonist), and VIP from BACHEM (Torrance, CA); MRS2500 (selective P2Y1 purinoceptor antagonist) and MRS2365 (selective P2Y1 purinoceptor agonist) from Tocris Bioscience (Ellisville, MO, USA); TTX from Wako (Osaka, Japan) or Abcam (Cambridge, UK); Apamin from Peptide Institute (Osaka, Japan) or Santa Cruz Biotechnology (Santa Cruz, CA); Atropine and L-NNA from MilliporeSigma (Burlington, MA).
+ Open protocol
+ Expand
6

Pharmacological Modulation of Vascular Function

Check if the same lab product or an alternative is used in the 5 most similar protocols
The drugs used were ACh hydrochloride (Daiichi Pharmaceutical, Tokyo, Japan), L-phenylephrine hydrochloride, 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole (TRAM-34), 18-β-glycyrrhetinic acid, diclofenac sodium, and DAB (Sigma Chemical Co, St Louis, MO, USA), apamin, charybdotoxin, and L-NNA (Peptide Institute Inc., Osaka, Japan), A23187 (Merck Chemicals GmbH, Darmstadt, Germany), NOC-7 (Dojindo Laboratories, Kumamoto, Japan), guanethidine (Tokyo Kasei, Tokyo, Japan), and Fura 2-acetoxymethyl ester (Molecular Probes, Eugene, OR, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!